Draft:Itamar Medical

Itamar Medical Launches Enhancements to WatchPAT™ Product Line at SLEEP 2021

Retrieved on: 
Monday, June 7, 2021

CAESAREA, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced two enhancements to its WatchPAT product line that the Company plans to unveil on June 11 during the Virtual SLEEP 2021 Conference, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society.

Key Points: 
  • CAESAREA, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced two enhancements to its WatchPAT product line that the Company plans to unveil on June 11 during the Virtual SLEEP 2021 Conference, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society.
  • This new service, WatchPAT with SleePath, will be offered to sleep clinics and will be customizable based on the specific needs of the sleep clinic and their patients.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.
  • Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs.

Itamar Medical Appoints Brad Fluegel to its Board of Directors

Retrieved on: 
Monday, May 24, 2021

CAESAREA, Israel, May 24, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Brad Fluegel to its Board of Directors.

Key Points: 
  • CAESAREA, Israel, May 24, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Brad Fluegel to its Board of Directors.
  • Most recently, Mr. Fluegel was Senior Vice President, Chief Healthcare Commercial Market Development Officer for Walgreens Co.
  • We are delighted to welcome Brad to Itamars board, said Dr. Giora Yaron, Chairman of Itamars Board of Directors.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.

Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021

Retrieved on: 
Wednesday, May 5, 2021

Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.

Key Points: 
  • Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.
  • Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs.
  • The Company\xe2\x80\x99s key product, WatchPAT, is commercially available within major markets including the US, Japan, and Europe.
  • Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information, visit www.itamar-medical.com\n'

Itamar Medical Announces Pricing of Public Offering of American Depositary Shares

Retrieved on: 
Friday, February 5, 2021

CAESAREA, Israel, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Itamar Medical or the Company) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the pricing of its public offering of 3,049,130 American Depositary Shares (ADSs) at a public offering price of $22.75 per ADS.

Key Points: 
  • CAESAREA, Israel, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Itamar Medical or the Company) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the pricing of its public offering of 3,049,130 American Depositary Shares (ADSs) at a public offering price of $22.75 per ADS.
  • Limited Partnership (the Selling Shareholder), is selling 1,080,664 ADSs in the offering.
  • The offering is expected to close on February 9, 2021, subject to customary closing conditions.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders.

Itamar Medical Announces Proposed Offering of American Depositary Shares

Retrieved on: 
Thursday, February 4, 2021

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Itamar Medical or the Company) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed public offering of American Depositary Shares (ADSs) of the Company.

Key Points: 
  • CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Itamar Medical or the Company) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed public offering of American Depositary Shares (ADSs) of the Company.
  • The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.
  • Piper Sandler, Cowen and SVB Leerink are acting as joint bookrunners for the proposed offering.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders.

Itamar Medical Appoints Scott P. Serota to its Board of Directors

Retrieved on: 
Wednesday, January 27, 2021

CAESAREA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Scott P. Serota to its Board of Directors.

Key Points: 
  • CAESAREA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Scott P. Serota to its Board of Directors.
  • Prior to joining BCBSA, Mr. Serota was president and CEO of Chicago-based Rush Prudential Health Plans.
  • We are delighted to welcome Scott to Itamars board, said Dr. Giora Yaron, Chairman of Itamars Board of Directors.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.

Itamar Medical Announces Additional 16 Million Covered Lives for WatchPAT™, the Only Single-Use Sleep Apnea Test that Meets Guidelines

Retrieved on: 
Wednesday, December 16, 2020

In November 2020 BCBS of Louisiana, covering 1.5 million lives, also published updated medical policy including PAT based HSATs.

Key Points: 
  • In November 2020 BCBS of Louisiana, covering 1.5 million lives, also published updated medical policy including PAT based HSATs.
  • WatchPAT, based on the PAT technology, oximetry and actigraphy, is used for diagnosing Sleep Apnea in the home environment.
  • Itamar Medicals WatchPAT ONE is the only FDA-approved single-use HSAT that meets Practice Guidelines currently available on the market.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.

Itamar Medical Comments on U.S. Centers for Medicare & Medicaid Services (CMS) 2021 Fee Schedule with Reimbursement Update for Home Sleep Apnea Testing

Retrieved on: 
Wednesday, December 9, 2020

Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.

Key Points: 
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.
  • Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.
  • Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs.
  • The Companys key product, WatchPAT, is commercially available within major markets including the US, Japan, and Europe.

Itamar Medical to Participate in the Piper 32nd Annual Virtual Healthcare Conference

Retrieved on: 
Tuesday, November 17, 2020

CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, today announced the company will participate in the upcoming Piper Virtual Healthcare Conference.

Key Points: 
  • CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, today announced the company will participate in the upcoming Piper Virtual Healthcare Conference.
  • Format: Fireside chat available the week of November 23, 2020
    Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.
  • Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.
  • Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs.

Itamar Medical to Report Third Quarter Financial Results and Host Conference Call on Tuesday, November 17, 2020

Retrieved on: 
Tuesday, November 3, 2020

The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update.

Key Points: 
  • The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update.
  • The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO.
  • To participate via phone, please use the following dial in information:
    Please log in approximately 10 minutes prior to the scheduled start time.
  • Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders.